Home NDC 0378-3123 Repaglinide
Product NDC 0378-3123
11-digit product format 003783123
Labeler code 0378
Product ID 0378-3123_982ba2c2-0ba7-47f4-ad30-51788f52e634
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name repaglinide
Dosage form TABLET
Route ORAL
Labeler Mylan Pharmaceuticals Inc.
Application ANDA090252
Marketing category ANDA
Marketing start 2014-01-22
Marketing end 2019-06-30
Substance REPAGLINIDE
Active strength 2 mg/1
Pharmacologic classes Glinide [EPC],Potassium Channel Antagonists [MoA]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0378-3123-01 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0378-3123-01 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0378-3123-01 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0378-3123-01 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0378-3123-01 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0378-3123-01 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0378-3123-01 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0378-3123-01 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0378-3123-01 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0378-3123-01 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0378-3123-01 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0378-3123-01 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A090252-001 REPAGLINIDE REPAGLINIDE 0.5MG TABLET / ORAL 2013-08-23 A090252-002 REPAGLINIDE REPAGLINIDE 1MG TABLET / ORAL 2014-01-22 A090252-003 REPAGLINIDE REPAGLINIDE 2MG TABLET / ORAL 2014-01-22
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A090252-001 REPAGLINIDE 0.5MG TABLET / ORAL 2013-08-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A090252-002 REPAGLINIDE 1MG TABLET / ORAL 2014-01-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A090252-003 REPAGLINIDE 2MG TABLET / ORAL 2014-01-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090252-001 REPAGLINIDE 0.5MG TABLET / ORAL 2013-08-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090252-002 REPAGLINIDE 1MG TABLET / ORAL 2014-01-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090252-003 REPAGLINIDE 2MG TABLET / ORAL 2014-01-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A090252-001 REPAGLINIDE 0.5MG TABLET / ORAL 2013-08-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A090252-002 REPAGLINIDE 1MG TABLET / ORAL 2014-01-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A090252-003 REPAGLINIDE 2MG TABLET / ORAL 2014-01-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090252-001 REPAGLINIDE 0.5MG TABLET / ORAL 2013-08-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090252-002 REPAGLINIDE 1MG TABLET / ORAL 2014-01-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090252-003 REPAGLINIDE 2MG TABLET / ORAL 2014-01-22 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090252-001 REPAGLINIDE 0.5MG TABLET / ORAL 2013-08-23 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090252-002 REPAGLINIDE 1MG TABLET / ORAL 2014-01-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090252-003 REPAGLINIDE 2MG TABLET / ORAL 2014-01-22 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090252-001 REPAGLINIDE 0.5MG TABLET / ORAL 2013-08-23 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090252-002 REPAGLINIDE 1MG TABLET / ORAL 2014-01-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090252-003 REPAGLINIDE 2MG TABLET / ORAL 2014-01-22 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090252-001 REPAGLINIDE 0.5MG TABLET / ORAL 2013-08-23 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090252-002 REPAGLINIDE 1MG TABLET / ORAL 2014-01-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090252-003 REPAGLINIDE 2MG TABLET / ORAL 2014-01-22 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090252-001 REPAGLINIDE 0.5MG TABLET / ORAL 2013-08-23 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090252-002 REPAGLINIDE 1MG TABLET / ORAL 2014-01-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090252-003 REPAGLINIDE 2MG TABLET / ORAL 2014-01-22 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090252-001 REPAGLINIDE 0.5MG TABLET / ORAL 2013-08-23 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090252-002 REPAGLINIDE 1MG TABLET / ORAL 2014-01-22 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090252-003 REPAGLINIDE 2MG TABLET / ORAL 2014-01-22 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A090252-001 REPAGLINIDE 0.5MG TABLET / ORAL 2013-08-23 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A090252-002 REPAGLINIDE 1MG TABLET / ORAL 2014-01-22 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A090252-003 REPAGLINIDE 2MG TABLET / ORAL 2014-01-22 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A090252-001 REPAGLINIDE 0.5MG TABLET / ORAL 2013-08-23 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A090252-002 REPAGLINIDE 1MG TABLET / ORAL 2014-01-22 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A090252-003 REPAGLINIDE 2MG TABLET / ORAL 2014-01-22 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A090252-001 REPAGLINIDE 0.5MG TABLET / ORAL 2013-08-23 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A090252-002 REPAGLINIDE 1MG TABLET / ORAL 2014-01-22 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A090252-003 REPAGLINIDE 2MG TABLET / ORAL 2014-01-22 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A090252-001 REPAGLINIDE 0.5MG TABLET / ORAL 2013-08-23 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A090252-002 REPAGLINIDE 1MG TABLET / ORAL 2014-01-22 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A090252-003 REPAGLINIDE 2MG TABLET / ORAL 2014-01-22 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A090252-001 REPAGLINIDE 0.5MG TABLET / ORAL 2013-08-23 8072bd15b7f6…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2019-07-19 19:46 UTC 2019-07 A090252-002 AB 1 ea99ee380514…2019-07-19 19:46 UTC 2019-07 A090252-003 AB 1 ea99ee380514…